Plavix clopidogrel regulatory update

FDA approved generic versions of cardiovascular drug Plavix clopidogrel. Sanofi and Bristol-Myers market the adenosine diphosphate (ADP) receptor (P2Y12) antagonist, which had U.S. sales of €4.8 bill...